Latest News

STAT Plus: Startup Spotlight: Vedanta Biosciences eyes large-scale clinical trials for microbiome drugs

Hundreds of millions of dollars have flowed to Boston-area companies investigating how to manipulate the microbiome within everyone to treat a plethora of illnesses, from serious gastrointestinal infections to food allergies to cancer.

The latest addition to that figure is $27 million to Vedanta Biosciences, which announced its Series C round on Dec. 24. The company has raised $82 million since it launched in 2010, making it one of the best-funded private companies working on microbiome therapeutics in the area. It also announced a partnership with Bristol-Myers Squibb in December.

Continue to STAT Plus to read the full story…

Source link

Related posts

Maternal and child health and nutrition: Week 1 of the PLOS Medicine Special Issue


Woman from Chinese city Wuhan lands in Bangkok with mysterious Corona virus infection


Scientists Make MRI Practical for Breast Cancer Screening


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World